NeuroMetrix Reports High Level of Media Coverage for Quell in First Quarter
BOSTON–(BUSINESS WIRE)–$NURO #NeuroMetrix–NeuroMetrix, Inc. (NASDAQ:NURO) today reported continued strong media
attention focusing on the company’s innovative Quell®
Wearable Pain Relief Technology™. Highlights include:
-
Newsweek – This FDA-approved
wearable says it relieves chronic pain without any drugs -
Boston Globe – FDA approves
upgrade to Quell, a dongle that zaps away pain -
Pain Medicine News – Upgraded
wearable pain relief device cleared by FDA -
MobiHealth News – NeuroMetrix
gets FDA clearance for smartphone-controlled Quell device -
Drug Store News – Quell
makes top 10 in CES’ Last Gadget Standing event -
Consumer Reports – Quell
wearable might deliver chronic pain relief without drugs -
The Source – Multi-billion
dollar wearables tech sector is the star of CES 2016 -
Huffington Post – Sleep
and pain at the Consumer Electronics Show -
GetConnected – Tech
heavy pain relief that’s drug free! -
A Sweet Life – Quell,
a new treatment for neuropathy without drugs -
Drug Store News – Quell
pain relief wearable a winner at SXSW Interactive Innovation Awards -
Black Enterprise – Pain
relieving wearable, gene editing software win awards at SXSW 2016 -
The Street Insider – NeuroMetrix
(NURO) says Quell available at Target starting in April -
Boston Globe – Target
to sell NeuroMetrix pain-relief device -
Oprah O Magazine – Three
gadgets that could erase your joint pain -
Puget Sound Business Journal – Premera
to offer employees wearable pain relief it found at CES
“We are pleased with the increased attention Quell has attracted in the
media during the first quarter of 2016,” said Frank McGillin, Senior
Vice President and General Manager, Consumer of NeuroMetrix. “We are
proud to see Quell reviewed in top tier media outlets such as Newsweek
and Consumer Reports, and continued coverage in the Boston Globe.”
About Quell Wearable Pain Relief Technology
Quell is an easy-to-use, over-the-counter device for relief of chronic
pain. This wearable device utilizes NeuroMetrix’s patented technology to
provide widespread pain relief. In a recent clinical study, Quell
improved chronic pain in 81% of participants. Quell is currently
available through select healthcare professionals, retailers and online
at www.QuellRelief.com.
About NeuroMetrix
NeuroMetrix is an innovative healthcare company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
Contacts
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com